Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study.

Craig B H SurmanDaniel M WalshNora HorickMaura DiSalvoChloe Hutt VaterDaniel Kaufman

Published in: The Journal of clinical psychiatry (2023)

Trial Registration: ClinicalTrials.gov identifier: NCT04839562.

Keyphrases